ClinicalTrials.Veeva

Find clinical trials for Triple Negative Breast Cancer in Columbus, OH

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Breast Cancer
Cancer
Carcinoma
Squamous Cell Carcinoma of Head and Neck
Endometrial Cancer
Non-Small-Cell Lung Carcinoma
Melanoma

Triple Negative Breast Cancer trials near Columbus, OH, USA:

Phase 1/1b Study of Oral PMD-026 in Patients With Metastatic Breast Cancer and Metastatic Triple Negative Breast Cancer

The purpose of this study is to test the safety and tolerability of PMD-026 in patients with metastatic breast cancer and triple...

Active, not recruiting
Metastatic Breast Cancer
Triple Negative Breast Cancer
Drug: PMD-026

Phase 1

Phoenix Molecular Designs

Columbus, Ohio, United States and 8 other locations

immune response and demonstrate efficacy in patients with advanced triple-negative breast cancer.This study will ...

Active, not recruiting
Triple-negative Breast Cancer
Biological: Pembrolizumab
Biological: AE37 Peptide vaccine

Phase 2

NuGenerex Immuno-Oncology

Columbus, Ohio, United States and 5 other locations

pelareorep and to see how well they work in treating patients with triple negative breast cancer that has spread ...

Enrolling
Anatomic Stage IV Breast Cancer AJCC v8
Prognostic Stage IV Breast Cancer AJCC v8
Other: Questionnaire Administration
Biological: Retifanlimab

Phase 2

Mridula George, MD

Columbus, Ohio, United States and 1 other location

This research study is studying a drug called Carboplatin with or without another study drug, Nivolumab as a possible treatment for triple-n ...

Active, not recruiting
Breast Cancer
Drug: Carboplatin
Drug: Nivolumab

Phase 2

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Columbus, Ohio, United States and 9 other locations

doxorubicin and cyclophosphamide (AC) or epirubicin and cyclophosphamide (EC). Usually, after neoadjuvant therapy and surgery for triple ne ...

Active, not recruiting
Triple Negative Breast Cancer
Drug: Placebo
Drug: Atezolizumab

Phase 3

National Surgical Adjuvant Breast and Bowel Project Foundation (NSABP)

Columbus, Ohio, United States and 216 other locations

or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after su...

Enrolling
Triple Negative Breast Cancer
Drug: Capecitabine
Drug: Sacituzumab govitecan-hziy (SG)

Phase 3

Gilead Sciences
Gilead Sciences

Columbus, Ohio, United States and 110 other locations

Event Free Survival (EFS), in women with residual hormone receptor negative, HER2-negative ("triple negative") re ...

Enrolling
Breast Cancer
Procedure: Breast Surgery
Procedure: Core Biopsy/Cryoablation

Phase 2

The University of Texas System (UT)
The University of Texas System (UT)

Columbus, Ohio, United States and 3 other locations

previously untreated, locally advanced, inoperable or metastatic triple-negative breast cancer whose tumors do no...

Enrolling
Triple Negative Breast Cancer
PD-L1 Negative
Drug: Paclitaxel
Drug: Gemcitabine

Phase 3

Gilead Sciences
Gilead Sciences

Columbus, Ohio, United States and 506 other locations

with previously untreated, locally advanced inoperable or metastatic triple-negative breast cancer, whose tumors ...

Enrolling
Triple Negative Breast Cancer
PD-L1 Positive
Drug: Pembrolizumab
Drug: Paclitaxel

Phase 3

Gilead Sciences
Gilead Sciences

Columbus, Ohio, United States and 508 other locations

This is a Phase III, randomised, open-label, 2 arm, multicentre, international study assessing the efficacy and safety of Dato-DXd compared with ICC...

Enrolling
Breast Cancer
Drug: Carboplatin
Drug: Nab-paclitaxel

Phase 3

AstraZeneca
AstraZeneca

Columbus, Ohio, United States and 273 other locations

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems